Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation

Karen K. Ballen(University of Virginia Health System), Marcie Riches(Medical College of Wisconsin), Min Chen(Allen Institute for Brain Science), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Michael R. Verneris(NHS Blood and Transplant), Tom F.W. Wolfs(KU Leuven), Edmund K. Waller(Emory University), Margaret L. MacMillan(University of Minnesota Medical Center), Paul Szabolcs(Children's Hospital of Pittsburgh), Ibrahim Ahmed(Children's Mercy Hospital), Harry C. Schouten, Kirsten M. Williams(National Institutes of Health), Michael Boeckh(Fred Hutch Cancer Center), Hillard M. Lazarus(University Hospitals of Cleveland), Caroline A. Lindemans(University Medical Center Utrecht), Joseph H. Antin(Dana-Farber Cancer Institute), Krishna V. Komanduri(University of Miami), Jo‐Anne H. Young(University of Minnesota System), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Baldeep Wirk(Boston University), Hisham Abdel‐Azim(University of Southern California), Daniel J. Weisdorf(University of Minnesota), Celalettin Üstün(Rush University Medical Center), Joseph Rosenthal(City Of Hope National Medical Center), Biju George(Westmead Hospital), Ami S. Bhatt(Stanford University), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Jan Storek(University of Washington), Jeffery J. Auletta(NHS Blood and Transplant), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bipin N. Savani(Vanderbilt University Medical Center), George Chen(Yale University), David A. Margolis(Medical College of Wisconsin), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Kwang Woo Ahn(Medical College of Wisconsin), Mary J. Laughlin(Cleveland Cord Blood Center), John R. Wingard(University of Florida Health)
Transplantation and Cellular Therapy
June 23, 2016
Cited by 87


Related Papers